Grantham, Mayo, Van Otterloo & Co. LLC
- SEC CIK
- 0001352662
- Latest filing
- Aug 13, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 8,794,077
- Value
- $798.0M
- % of portfolio
- 1.8%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 8,794,077 | $798.0M | 1.8% | −116,868−1.3% | Reduced | Holders |
| Q1 2026 | 8,910,945 | $914.9M | 2.3% | +428,392+5.1% | Added | Holders |
| Q4 2025 | 8,482,553 | $1.06B | 2.7% | +306,069+3.7% | Added | Holders |
| Q3 2025 | 8,176,484 | $1.10B | 3.1% | +361,946+4.6% | Added | Holders |
| Q2 2025 | 7,814,538 | $1.06B | 3.2% | −293,045−3.6% | Reduced | Holders |
| Q1 2025 | 8,107,583 | $1.08B | 3.4% | +210,644+2.7% | Added | Holders |
| Q4 2024 | 7,896,939 | $893.2M | 2.9% | +787,251+11.1% | Added | Holders |
| Q3 2024 | 7,109,688 | $810.6M | 2.5% | +1,317,528+22.7% | Added | Holders |
| Q2 2024 | 5,792,160 | $601.9M | 2.0% | +384,152+7.1% | Added | Holders |
| Q1 2024 | 5,408,008 | $614.7M | 2.2% | +1,032,651+23.6% | Added | Holders |
| Q4 2023 | 4,375,357 | $481.6M | 2.1% | +710,501+19.4% | Added | Holders |
| Q3 2023 | 3,664,856 | $354.9M | 1.7% | +801,191+28.0% | Added | Holders |
| Q2 2023 | 2,863,665 | $312.2M | 1.4% | +1,215,172+73.7% | Added | Holders |
| Q1 2023 | 1,648,493 | $166.9M | 0.8% | +13,059+0.8% | Added | Holders |
| Q4 2022 | 1,635,434 | $179.6M | 1.0% | −15,800−1.0% | Reduced | Holders |
| Q3 2022 | 1,651,234 | $159.8M | 0.9% | +43,860+2.7% | Added | Holders |
| Q2 2022 | 1,607,374 | $174.6M | 0.9% | −40,129−2.4% | Reduced | Holders |
| Q1 2022 | 1,647,503 | $195.0M | 0.9% | −41,277−2.4% | Reduced | Holders |
| Q4 2021 | 1,688,780 | $237.7M | 1.1% | −67,118−3.8% | Reduced | Holders |
| Q3 2021 | 1,755,898 | $207.4M | 1.0% | +24,686+1.4% | Added | Holders |
| Q2 2021 | 1,731,212 | $200.7M | 1.0% | +6,799+0.4% | Added | Holders |
| Q1 2021 | 1,724,413 | $206.7M | 1.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.